Eevia Health Plc: Notice for Annual General Meeting for June 28, 2024
Eevia Health Plc, ("Eevia" or "The Company"), has today published the notice for the Annual General Meeting of Shareholders ("AGM") for June 28, 2024. The AGM will be held at the main office in Seinäjoki, Finland.
For immediate release
Seinäjoki, Finland 10.06.2024
The call for the AGM is made today, June 10th, 2024. The Record date is 17.6.2024. The market deadline for custodians to do temporary registrations is 24.6.2024 at 10:00 (Finnish time). All relevant information for the AGM, including details on how to participate, can be found in the notice, which may also be found together with relevant documents at the current site: https://investor.eeviahealth.com/corporate-governance/general-meetings/
This information is such that Eevia Health Plc is required to make public in accordance with the EU's Market Abuse Regulation (MAR). The information was made public by the Company's contact person above on June 10, 2024, at 16:59 CEST.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected]
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested sustainably.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA.
To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth.
Attached files
AGM-2024-Notice-of-the-Annual-General-Meeting-of-Shareholders.pdfEevia-Health-Oyj-Optionsprogram-2024-I-SWE-ENG.pdf
Press-release-per-June-10-2024-AGM-Press-release-2024.pdf
AGM-2024-Notice-of-the-Annual-General-Meeting-of-Shareholde_1.pdf
Om Eevia Health
Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.
